SETEK is a leading New Zealand medicinal cannabis company which aims to cultivate, extract, process and sell pharmaceutical grade, 100 percent NZ-certified organic medicinal cannabis extracts and medicines throughout the Asia Pacific region and beyond.
It holds a license to cultivate a prohibited plant for research purposes, including the cultivation of high THC cultivars.
The company recently purchased a 26-hectare greenfield site overlooking Lake Taupo to house its new facility, which will commence production in 2020 with an initial annual scaled production capacity of circa 17,000kg of dried flower for processing.
SETEK recently acquired a cannabis genetics company and a horticultural LED lighting company. Most recently, they signed a multi-year MoU with listed company, AFT Pharmaceuticals to work together in the research, development, commercialisation and distribution of cannabinoid-based medicines.
SETEK’s Advisory Board is headed by former Associate Health Minister, Hon Peter Dunne.